INSIGHT PROVIDER
Top Quartile
Xinyao (Criss) Wang

Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)

1.4k
Insights
738.5k
Views
579
Followers
China Health Care Equity Bottom-Up Thematic (Sector/Industry)

Top Sectors

Health Care
86%
Consumer Discretionary
5%
Consumer Staples
5%
Materials
2%
Information Technology
1%
Industrials
1%
Financials
1%
Communication Services
0%
Energy
0%

Top Verticals

Equity Bottom-Up
48%
Equity Capital Markets
34%
Thematic (Sector/Industry)
18%

Top Entities

Innovent Biologics Inc
208
BeiGene
194
Jiangsu Hengrui Medicine
173
Akeso Biopharma Inc
113
Shanghai Junshi Biosciences
97
WuXi AppTec
96
Wuxi Biologics
86
JD Health International
81
Remegen
79
Sino Biopharmaceutical
73

Top Countries

China
57%
Hong Kong
37.9%
United States
3.2%
Singapore
0.5%
Russia
0.2%
India
0.2%
Japan
0.2%
United Arab Emirates
0.2%
Saudi Arabia
0.1%
Germany
0.1%
x